119 related articles for article (PubMed ID: 25696841)
1. Impact of MYC on malignant behavior.
Ott G
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):100-6. PubMed ID: 25696841
[TBL] [Abstract][Full Text] [Related]
2. Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification.
Ott G; Rosenwald A; Campo E
Hematology Am Soc Hematol Educ Program; 2013; 2013():575-83. PubMed ID: 24319234
[TBL] [Abstract][Full Text] [Related]
3. Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification.
Ott G; Rosenwald A; Campo E
Blood; 2013 Dec; 122(24):3884-91. PubMed ID: 24009228
[TBL] [Abstract][Full Text] [Related]
4. MYC and aggressive B-cell lymphomas.
Slack GW; Gascoyne RD
Adv Anat Pathol; 2011 May; 18(3):219-28. PubMed ID: 21490439
[TBL] [Abstract][Full Text] [Related]
5. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
[TBL] [Abstract][Full Text] [Related]
6. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
Gebauer N; Bernard V; Feller AC; Merz H
Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
[TBL] [Abstract][Full Text] [Related]
7. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.
Ruzinova MB; Caron T; Rodig SJ
Am J Surg Pathol; 2010 Jun; 34(6):882-91. PubMed ID: 20442643
[TBL] [Abstract][Full Text] [Related]
8. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
9. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
[TBL] [Abstract][Full Text] [Related]
10. The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma.
Smith SM; Anastasi J; Cohen KS; Godley LA
Blood Cells Mol Dis; 2010 Dec; 45(4):317-23. PubMed ID: 20817505
[TBL] [Abstract][Full Text] [Related]
11. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
[TBL] [Abstract][Full Text] [Related]
12. MYC/BCL2 double-hit high-grade B-cell lymphoma.
Li S; Lin P; Young KH; Kanagal-Shamanna R; Yin CC; Medeiros LJ
Adv Anat Pathol; 2013 Sep; 20(5):315-26. PubMed ID: 23939148
[TBL] [Abstract][Full Text] [Related]
13. MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications.
Sewastianik T; Prochorec-Sobieszek M; Chapuy B; Juszczyński P
Biochim Biophys Acta; 2014 Dec; 1846(2):457-67. PubMed ID: 25199984
[TBL] [Abstract][Full Text] [Related]
14. MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management.
Cai Q; Medeiros LJ; Xu X; Young KH
Oncotarget; 2015 Nov; 6(36):38591-616. PubMed ID: 26416427
[TBL] [Abstract][Full Text] [Related]
15. Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
Lundin C; Hjorth L; Behrendtz M; Ehinger M; Biloglav A; Johansson B
Genes Chromosomes Cancer; 2013 Apr; 52(4):370-7. PubMed ID: 23225516
[TBL] [Abstract][Full Text] [Related]
16. Advances in the understanding of MYC-induced lymphomagenesis.
Klapproth K; Wirth T
Br J Haematol; 2010 May; 149(4):484-97. PubMed ID: 20346013
[TBL] [Abstract][Full Text] [Related]
17. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
Boerma EG; Siebert R; Kluin PM; Baudis M
Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440
[TBL] [Abstract][Full Text] [Related]
18. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
Haralambieva E; Boerma EJ; van Imhoff GW; Rosati S; Schuuring E; Müller-Hermelink HK; Kluin PM; Ott G
Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.
Swerdlow SH
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):90-9. PubMed ID: 25696840
[TBL] [Abstract][Full Text] [Related]
20. Translocations involving c-myc and c-myc function.
Boxer LM; Dang CV
Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
